MARKET

ETON

ETON

Eton Pharmaceuticals
NASDAQ
30.40
+0.69
+2.32%
Opening 11:31 05/13 EDT
OPEN
29.51
PREV CLOSE
29.71
HIGH
30.58
LOW
29.51
VOLUME
77.61K
TURNOVER
--
52 WEEK HIGH
32.31
52 WEEK LOW
13.09
MARKET CAP
831.74M
P/E (TTM)
-177.7778
1D
5D
1M
3M
1Y
5Y
1D
H.C. Wainwright Remains a Buy on Eton Pharmaceuticals (ETON)
TipRanks · 13h ago
Eton Pharma management attends Jefferies Global Healthcare Conference webcast
PUBT · 1d ago
Weekly Report: what happened at ETON last week (0504-0508)?
Weekly Report · 2d ago
Eton Pharmaceuticals to report Q1 2026 results, host conference call
PUBT · 05/04 20:38
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eton Pharmaceuticals (ETON), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)
TipRanks · 05/04 13:10
Weekly Report: what happened at ETON last week (0427-0501)?
Weekly Report · 05/04 09:05
Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol
Dow Jones · 05/01 19:00
Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution
TipRanks · 05/01 14:39
More
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.

Webull offers Eton Pharmaceuticals Inc stock information, including NASDAQ: ETON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ETON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ETON stock methods without spending real money on the virtual paper trading platform.